| __timestamp | Axsome Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 293000 |
| Thursday, January 1, 2015 | 6776987 | 1002000 |
| Friday, January 1, 2016 | 21199860 | 888000 |
| Sunday, January 1, 2017 | 19957616 | 19623000 |
| Monday, January 1, 2018 | 23495055 | 30421000 |
| Tuesday, January 1, 2019 | 53647067 | 34794000 |
| Wednesday, January 1, 2020 | 70244579 | 28304000 |
| Friday, January 1, 2021 | 58060725 | 56886000 |
| Saturday, January 1, 2022 | 57947447 | 100894000 |
| Sunday, January 1, 2023 | 97944000 | 159765000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Axsome Therapeutics, Inc. and Viridian Therapeutics, Inc. have been at the forefront of this race.
Since 2014, Axsome has steadily increased its R&D investments, peaking in 2023 with a remarkable 128% increase from its 2014 spending. Meanwhile, Viridian has shown an even more dramatic rise, with its R&D expenses skyrocketing by over 540% during the same period. This surge underscores Viridian's aggressive push towards groundbreaking therapies.
In 2023, Viridian outspent Axsome by approximately 63%, highlighting its strategic focus on expanding its therapeutic pipeline. As these two companies continue to innovate, their R&D spending trends offer a glimpse into the future of biotech advancements.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Axsome Therapeutics, Inc.
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Gilead Sciences, Inc. and Axsome Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Zoetis Inc. vs Axsome Therapeutics, Inc.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Research and Development Investment: Viatris Inc. vs Axsome Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.